Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $16,686 | 9 | 52.1% |
| Food and Beverage | $8,406 | 448 | 26.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $6,745 | 2 | 21.1% |
| Education | $193.68 | 6 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic, Inc. | $23,436 | 12 | $0 (2022) |
| ABBVIE INC. | $1,497 | 104 | $0 (2024) |
| Janssen Biotech, Inc. | $1,053 | 46 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $983.59 | 56 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $626.57 | 38 | $0 (2024) |
| Mauna Kea Technologies, Inc. | $577.44 | 15 | $0 (2023) |
| Celgene Corporation | $352.95 | 21 | $0 (2024) |
| BOSTON SCIENTIFIC CORPORATION | $350.55 | 5 | $0 (2021) |
| Merck Sharp & Dohme LLC | $293.71 | 18 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $263.25 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,063 | 65 | ABBVIE INC. ($300.41) |
| 2023 | $2,532 | 139 | ABBVIE INC. ($492.35) |
| 2022 | $1,865 | 82 | Medtronic, Inc. ($385.17) |
| 2021 | $24,772 | 89 | Medtronic, Inc. ($23,051) |
| 2020 | $720.34 | 42 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($90.96) |
| 2019 | $285.90 | 21 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($88.94) |
| 2018 | $208.36 | 12 | Takeda Pharmaceuticals U.S.A., Inc. ($64.61) |
| 2017 | $584.07 | 15 | BOSTON SCIENTIFIC CORPORATION ($332.69) |
All Payment Transactions
465 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $1.03 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $23.27 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $9.89 | General |
| Category: IMMUNOLOGY | ||||||
| 10/30/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $9.70 | General |
| Category: IMMUNOLOGY | ||||||
| 10/09/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $0.96 | General |
| Category: IMMUNOLOGY | ||||||
| 09/16/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $8.57 | General |
| Category: IMMUNOLOGY | ||||||
| 08/29/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $1.72 | General |
| Category: IMMUNOLOGY | ||||||
| 08/20/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $7.44 | General |
| Category: IMMUNOLOGY | ||||||
| 08/12/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: Gastroenterology | ||||||
| 07/29/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 07/23/2024 | Sandoz Inc. | HYRIMOZ (Biological) | Food and Beverage | In-kind items and services | $20.17 | General |
| Category: Immunology | ||||||
| 07/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $2.05 | General |
| Category: IMMUNOLOGY | ||||||
| 07/13/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: IMMUNOLOGY | ||||||
| 07/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: Gastroenterology | ||||||
| 06/28/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $24.32 | General |
| Category: Immunology | ||||||
| 06/26/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.45 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 06/25/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $22.68 | General |
| Category: Immunology | ||||||
| 06/07/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: IMMUNOLOGY | ||||||
| 06/05/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: INTERNAL MEDICINE | ||||||
| 06/03/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $32.31 | General |
| Category: Immunology | ||||||
| 05/31/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: INTERNAL MEDICINE | ||||||
| 05/21/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $17.10 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 05/21/2024 | Celltrion USA Inc. | ZYMFENTRA (Biological) | Education | In-kind items and services | $16.95 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/16/2024 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $19.82 | General |
| 05/14/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $25.38 | General |
| Category: THERAPY FOR CSID | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 964 | 1,672 | $358,892 | $73,575 |
| 2022 | 8 | 1,045 | 2,167 | $417,467 | $85,928 |
| 2021 | 7 | 984 | 1,933 | $346,825 | $77,356 |
| 2020 | 7 | 877 | 1,877 | $345,190 | $70,647 |
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 409 | 863 | $184,140 | $21,035 | 11.4% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Office | 2023 | 198 | 390 | $43,680 | $19,854 | 45.5% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2023 | 152 | 186 | $25,854 | $11,667 | 45.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 79 | 105 | $28,620 | $9,011 | 31.5% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 28 | 28 | $23,205 | $3,428 | 14.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 28 | 28 | $10,696 | $3,166 | 29.6% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 39 | 41 | $27,370 | $2,370 | 8.7% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 18 | 18 | $12,499 | $2,309 | 18.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 13 | 13 | $2,828 | $735.26 | 26.0% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2022 | 465 | 1,228 | $265,248 | $29,783 | 11.2% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Office | 2022 | 256 | 533 | $59,696 | $27,008 | 45.2% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2022 | 199 | 247 | $34,333 | $15,724 | 45.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 53 | 84 | $20,160 | $7,042 | 34.9% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 20 | 20 | $15,000 | $2,378 | 15.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 16 | 16 | $5,600 | $1,924 | 34.4% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 25 | 27 | $14,850 | $1,709 | 11.5% |
| 43450 | Dilation of esophagus | Facility | 2022 | 11 | 12 | $2,580 | $360.01 | 14.0% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Office | 2021 | 269 | 587 | $65,744 | $29,560 | 45.0% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2021 | 451 | 1,016 | $219,456 | $24,661 | 11.2% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2021 | 182 | 225 | $31,275 | $14,119 | 45.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 45 | 67 | $16,080 | $6,002 | 37.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 13 | 13 | $4,550 | $1,529 | 33.6% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 12 | 12 | $6,600 | $850.77 | 12.9% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 12 | 13 | $3,120 | $633.87 | 20.3% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Office | 2020 | 236 | 566 | $63,392 | $26,287 | 41.5% |
About Dr. Mark Molos, MD
Dr. Mark Molos, MD is a Gastroenterology healthcare provider based in Weston, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1427036797.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Molos, MD has received a total of $32,030 in payments from pharmaceutical and medical device companies, with $1,063 received in 2024. These payments were reported across 465 transactions from 43 companies. The most common payment nature is "Consulting Fee" ($16,686).
As a Medicare-enrolled provider, Molos has provided services to 3,870 Medicare beneficiaries, totaling 7,649 services with total Medicare billing of $307,506. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Weston, FL
- Active Since 01/05/2006
- Last Updated 11/26/2025
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1427036797
Products in Payments
- ENTYVIO (Biological) $723.51
- STELARA (Biological) $723.22
- RINVOQ (Biological) $453.31
- ZEPOSIA (Drug) $352.95
- GENERAL - THERAPIES (Device) $332.69
- XIFAXAN (Drug) $329.07
- REMICADE (Biological) $311.96
- DUPIXENT (Biological) $307.45
- HUMIRA (Biological) $302.46
- TRULANCE (Drug) $285.47
- DIFICID (Drug) $278.13
- SKYRIZI (Biological) $202.13
- OMVOH (Drug) $186.22
- INJECTAFER (Drug) $179.94
- IBSRELA (Drug) $176.95
- LINZESS (Drug) $168.15
- ZENPEP (Drug) $166.35
- OCALIVA (Drug) $156.75
- XELJANZ (Drug) $143.71
- Humira (Biological) $120.24
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Weston
Dr. Kalyan Bhamidimarri, Md., Mph, MD., MPH
Gastroenterology — Payments: $112,181
Andrew (Andrzej) Ukleja, M.d, M.D
Gastroenterology — Payments: $49,228
Dr. Nicole Palekar, M.d, M.D
Gastroenterology — Payments: $47,953
Alison Schneider, M.d, M.D
Gastroenterology — Payments: $23,293
Dr. Adalberto Gonzalez, M.d, M.D
Gastroenterology — Payments: $5,317
Dr. Bayarmaa Mandzhieva, Md, MD
Gastroenterology — Payments: $4,425